280. Huge arteriovenous malformation with cervicofacial or limb lesion
22 clinical trials, 26 drugs (DrugBank: 13 drugs), 11 drug target genes, 147 drug target pathways
Searched query = "Huge arteriovenous malformation with cervicofacial or limb lesion", "Huge arteriovenous malformation", "Arteriovenous malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2019-003573-26-BE (EUCTR) | 18/12/2019 | Evaluating the safety and efficacy of Trametinib in Arterio-Venous Malformations that are refractory to standard care | Monocentric pilot trial evaluating efficacy of Trametinib in Arteriovenous Malformations that are refractory to standard treatments or for which standard treatment are contra-indicated - TRAMAV | Arteriovenous Malformations that are refractory to standard treatments or for which standard treatment are contra-indicated;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] | Trade Name: Mekinist Product Name: Mekinist | Cliniques universitaires Saint-Luc | NULL | NA | Female: yes Male: yes | 20 | Phase 2 | Belgium |